Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2 (Q36695749)
Jump to navigation
Jump to search
scientific article published on 18 March 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2 |
scientific article published on 18 March 2015 |
Statements
Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2 (English)
David J Kwiatkowski
Michael R Palmer
David Franz
Scott Segal
David Chen
18 March 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference